Your Health, We Care
Strong CYP3A Inducers Concomitant use of Tivozanib with a strong CYP3A inducer decreases tivozanib exposure, which may reduce Tivozanib anti-tumor activity. Avoid concomitant use of strong CYP3A inducers with Tivozanib.
from FDA，2021.03
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp:
